Hematology & Oncology Doctors in Denton, TX Accepting Medicare

6 Hematology & Oncology doctors found. Showing 1 - 6

Dr. Ajit M Dave, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3327 Colorado Blvd, Suite #200, Denton, TX 76210 Phone: 940-382-4060    Fax: 940-380-9282

Camille Johnson, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2600 Scripture St, Denton, TX 76201 Phone: 940-382-1022    Fax: 940-323-1190

Dr. Sharad Kumar Jain, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3720 S I-35 E, Denton, TX 76210 Phone: 940-382-1022    Fax: 940-380-7904

Gary Lu, M.D., PH.D Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2600 Scripture St, Denton, TX 76201 Phone: 940-382-1022    Fax: 940-323-1190

Mohammad Qasim, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2900 N I 35 Ste 111, Denton, TX 76201 Phone: 817-759-7000    Fax: 817-759-7027

Dr. Ketaki B. Dave, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3720 S I-35 E, Denton, TX 76210 Phone: 970-382-1022    Fax: 970-380-7947

News Archive

Rat pups exposed to tobacco smoke are at higher risk of developing metabolic disease

While many parents-to-be are aware that the health of their baby starts before they've actually arrived into the world, recent research reveals that "harm" (i.e., tobacco smoke, dirty air, poor nutrition, even preeclampsia) may not present itself disease-wise until well into adulthood or when a second harmful "hit" triggers the individual's susceptibility.

Personalis announces availability of Genome Services for Research

Personalis, Inc. today announced availability of its Genome Services for Research, focusing on accuracy in sequencing, analysis, and interpretation of human genomes. Personalis believes that accuracy is crucial in medicine, both in research and ultimately in clinical use.

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.

Novavax announces new data from trivalent seasonal influenza VLP vaccine study

Novavax, Inc. announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains.

Study finds obesity and super obesity associated with increased risk of asthma

Asthma is reaching epidemic levels in the U.S., with 8 percent of the total population and 10 percent of the African-American population suffering from this disease. Obesity rates are also increasing, now affecting 34 percent of the population.

Read more Medical News

› Verified 5 days ago